{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:01:48Z","timestamp":1791223308196,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003565","name":"Ministry of Land, Infrastructure and Transport","doi-asserted-by":"publisher","award":["NTRH RF-2023001"],"award-info":[{"award-number":["NTRH RF-2023001"]}],"id":[{"id":"10.13039\/501100003565","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-13513-5","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T07:18:50Z","timestamp":1737530330000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Multimodal treatments and the risk of breast cancer-related lymphedema: insights from a nationally representative cohort in South Korea"],"prefix":"10.1186","volume":"25","author":[{"given":"Sung Hoon","family":"Jeong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Min","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miji","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye Seol","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ja-Ho","family":"Leigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon-Hee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"key":"13513_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. The Breast. 2022;66:15\u201323.","journal-title":"The Breast"},{"key":"13513_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-62200-x","volume":"10","author":"J Hwang","year":"2020","unstructured":"Hwang J, Bae H, Choi S, Yi H, Ko B, Kim N. Impact of air pollution on breast cancer incidence and mortality: a nationwide analysis in South Korea. Sci Rep. 2020;10:1\u20137.","journal-title":"Sci Rep"},{"key":"13513_CR3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.4143\/crt.2023.447","volume":"55","author":"MJ Kang","year":"2023","unstructured":"Kang MJ, Jung K-W, Bang SH, Choi SH, Park EH, Yun EH, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2020. Cancer Res Treat. 2023;55:385\u201399.","journal-title":"Cancer Res Treat."},{"key":"13513_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/SLA.0000000000003491","volume":"274","author":"HK Byun","year":"2021","unstructured":"Byun HK, Chang JS, Im SH, Kirova YM, Arsene-Henry A, Choi SH, et al. Risk of lymphedema following contemporary treatment for breast cancer: an analysis of 7617 consecutive patients from a multidisciplinary perspective. Ann Surg. 2021;274:170\u20138.","journal-title":"Ann Surg"},{"key":"13513_CR5","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","volume":"1","author":"T DiSipio","year":"2013","unstructured":"DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. The lancet Oncol. 2013;1:500\u201315.","journal-title":"The lancet Oncol"},{"key":"13513_CR6","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.1200\/JCO.2007.14.4899","volume":"26","author":"SC Hayes","year":"2008","unstructured":"Hayes SC, Janda M, Cornish B, Battistutta D, Newman B. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol. 2008;26:3536\u201342.","journal-title":"J Clin Oncol"},{"key":"13513_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1037\/bul0000084","volume":"143","author":"JC Franklin","year":"2017","unstructured":"Franklin JC, Ribeiro JD, Fox KR, Bentley KH, Kleiman EM, Huang X, et al. Risk factors for suicidal thoughts and behaviors: A meta-analysis of 50 years of research. Psychol Bull. 2017;143:187.","journal-title":"Psychol Bull"},{"key":"13513_CR8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.21037\/gs.2017.11.04","volume":"7","author":"TC Gillespie","year":"2018","unstructured":"Gillespie TC, Sayegh HE, Brunelle CL, Daniell KM, Taghian AG. Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments. Gland Surg. 2018;7:379.","journal-title":"Gland Surg"},{"key":"13513_CR9","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1200\/JCO.19.02896","volume":"38","author":"SA McLaughlin","year":"2020","unstructured":"McLaughlin SA, Brunelle CL, Taghian A. Breast cancer\u2013related lymphedema: risk factors, screening, management, and the impact of locoregional treatment. J ClinOncol. 2020;38:2341.","journal-title":"J ClinOncol"},{"key":"13513_CR10","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1245\/s10434-009-0452-2","volume":"16","author":"RJ Tsai","year":"2009","unstructured":"Tsai RJ, Dennis LK, Lynch CF, Snetselaar LG, Zamba GK, Scott-Conner C. The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol. 2009;16:1959\u201372.","journal-title":"Ann Surg Oncol"},{"key":"13513_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00520-022-07508-2","volume":"3","author":"A Shen","year":"2023","unstructured":"Shen A, Lu Q, Fu X, Wei X, Zhang L, Bian J, et al. Risk factors of unilateral breast cancer-related lymphedema: an updated systematic review and meta-analysis of 84 cohort studies. Supp Care Cancer. 2023;3:18.","journal-title":"Supp Care Cancer"},{"key":"13513_CR12","first-page":"191","volume":"164","author":"SR Harris","year":"2001","unstructured":"Harris SR, Hugi MR, Olivotto IA, Levine M. Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema CMAJ. 2001;164:191\u20139.","journal-title":"Lymphedema CMAJ"},{"key":"13513_CR13","doi-asserted-by":"publisher","first-page":"416","DOI":"10.4143\/crt.2014.079","volume":"47","author":"M Kim","year":"2015","unstructured":"Kim M, Park IH, Lee KS, Ro J, Jung S-Y, Lee S, et al. Breast cancer-related lymphedema after neoadjuvant chemotherapy. Cancer Res Treat. 2015;47:416\u201323.","journal-title":"Cancer Res Treat"},{"key":"13513_CR14","doi-asserted-by":"publisher","first-page":"13307","DOI":"10.4143\/crt.2015.463","volume":"48","author":"M Kim","year":"2016","unstructured":"Kim M, Shin KH, Jung S-Y, Lee S, Kang H-S, Lee ES, et al. Identification of prognostic risk factors for transient and persistent lymphedema after multimodal treatment for breast cancer. Cancer Res Treat. 2016;48:13307.","journal-title":"Cancer Res Treat"},{"key":"13513_CR15","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1111\/j.1365-2702.2007.02187.x","volume":"17","author":"JH Park","year":"2008","unstructured":"Park JH, Lee WH, Chung HS. Incidence and risk factors of breast cancer lymphoedema. J Clin Nurs. 2008;17:1450\u20139.","journal-title":"J Clin Nurs"},{"key":"13513_CR16","first-page":"799","volume":"46","author":"S Cheol Seong","year":"2017","unstructured":"Cheol Seong S, Kim Y-Y, Khang Y-H, Heon Park J, Kang H-J, Lee H, et al. Data resource profile: the national health information database of the National Health Insurance Service in South Korea. Int J Epidemiol. 2017;46:799\u2013800.","journal-title":"Int J Epidemiol"},{"key":"13513_CR17","doi-asserted-by":"publisher","first-page":"352","DOI":"10.4143\/crt.2021.044","volume":"54","author":"MS Yang","year":"2022","unstructured":"Yang MS, Park M, Back JH, Lee GH, Shin JH, Kim K, et al. Validation of cancer diagnosis based on the national health insurance service database versus the national cancer registry database in Korea. Cancer Res Treat. 2022;54:352\u201361.","journal-title":"Cancer Res Treat"},{"key":"13513_CR18","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2018.33.e276","volume":"33","author":"IY Chung","year":"2018","unstructured":"Chung IY, Lee J, Park S, Lee JW, Youn HJ, Hong JH, et al. Nationwide analysis of treatment patterns for Korean breast cancer survivors using National Health Insurance Service data. J Korean Med Sci. 2018;33: e276.","journal-title":"J Korean Med Sci"},{"key":"13513_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/cncr.32485","volume":"126","author":"J Lee","year":"2020","unstructured":"Lee J, Hur H, Lee JW, Youn HJ, Han K, Kim NW, et al. Long-term risk of congestive heart failure in younger breast cancer survivors: a nationwide study by the SMARTSHIP group. Cancer. 2020;126:181\u20138.","journal-title":"Cancer"},{"key":"13513_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.636378","volume":"11","author":"S Choi","year":"2021","unstructured":"Choi S, Lee YJ, Jeong JH, Jung J, Lee JW, Kim HJ, et al. Risk of endometrial cancer and frequencies of invasive endometrial procedures in young breast cancer survivors treated with tamoxifen: a nationwide study. Front Oncol. 2021;11: 636378.","journal-title":"Front Oncol"},{"key":"13513_CR21","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks AG, Winer EP. Breast cancer treatment: a review. JAMA. 2019;321:288\u2013300.","journal-title":"JAMA"},{"key":"13513_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ejendo\/lvad168","volume":"19","author":"J-S Yuk","year":"2024","unstructured":"Yuk J-S, Kim T, Cho H, Gwak G. Breast cancer risk association with postmenopausal hormone therapy: Health Insurance Database in South Korea\u2013based cohort study. Eur J Endocrinol. 2024;19:1\u201311.","journal-title":"Eur J Endocrinol"},{"key":"13513_CR23","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.1093\/aje\/kwm324","volume":"167","author":"S Suissa","year":"2008","unstructured":"Suissa S. Immortal time bias in pharmacoepidemiology. Am J Epidemiol. 2008;167:4929.","journal-title":"Am J Epidemiol"},{"key":"13513_CR24","doi-asserted-by":"publisher","first-page":"326","DOI":"10.5535\/arm.2016.40.2.326","volume":"40","author":"SI Park","year":"2016","unstructured":"Park SI, Yang EJ, Kim DK, Jeong HJ, Kim GC, Sim Y-J. Prevalence and epidemiological factors involved in cellulitis in Korean patients with lymphedema. Ann Rehabil Med. 2016;40:326\u201333.","journal-title":"Ann Rehabil Med"},{"key":"13513_CR25","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.3390\/jcm10204647","volume":"10","author":"S-J Lee","year":"2021","unstructured":"Lee S-J, Myong J-P, Lee Y-H, Cho E-J, Lee S-J, Kim C-J, et al. Lymphedema in endometrial cancer survivor: A nationwide cohort study. J Clin Med. 2021;10:4647.","journal-title":"J Clin Med"},{"key":"13513_CR26","doi-asserted-by":"publisher","first-page":"18915","DOI":"10.1038\/s41598-022-23683-y","volume":"12","author":"N-C Shih","year":"2022","unstructured":"Shih N-C, Kung P-T, Kuo W-Y, Tsai W-C. Association of treatment delay and stage with mortality in breast cancer: a nationwide cohort study in Taiwan. Sci Rep. 2022;12:18915.","journal-title":"Sci Rep"},{"key":"13513_CR27","first-page":"164","volume":"2","author":"J O'Toole","year":"2011","unstructured":"O\u2019Toole J, Taghian A. Risk Factors for Lymphedema after Breast Cancer Treatment. Breast Diseases: A Year Book Quarterly. 2011;2:164\u20135.","journal-title":"Breast Diseases: A Year Book Quarterly"},{"key":"13513_CR28","first-page":"2734","volume":"19","author":"SA Norman","year":"2010","unstructured":"Norman SA, Localio AR, Kallan MJ, Weber AL, Simoes Torpey HA, Potashnik SL, et al. Risk factors for lymphedema after breast cancer treatment. Cancer Epidemiol. 2010;19:2734\u201346.","journal-title":"Cancer Epidemiol"},{"key":"13513_CR29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"13513_CR30","first-page":"1288","volume":"57","author":"V Sundararajan","year":"2004","unstructured":"Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J ClinEpidemiol. 2004;57:1288\u201394.","journal-title":"J ClinEpidemiol"},{"key":"13513_CR31","unstructured":"Young JL. SEER summary staging manual 2000: codes and coding instructions: National Cancer Institute, National Institutes of Health. 2001."},{"key":"13513_CR32","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1001\/archsurg.137.11.1253","volume":"137","author":"SM Beaulac","year":"2002","unstructured":"Beaulac SM, McNair LA, Scott TE, LaMorte WW, Kavanah MT. Lymphedema and quality of life in survivors of early-stage breast cancer. Arch Surg. 2002;137:1253\u20137.","journal-title":"Arch Surg"},{"key":"13513_CR33","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927\u201333.","journal-title":"Lancet Oncol"},{"key":"13513_CR34","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569\u201375.","journal-title":"JAMA"},{"key":"13513_CR35","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1524-4741.2012.01252.x","volume":"18","author":"C Shah","year":"2012","unstructured":"Shah C, Arthur D, Riutta J, Whitworth P, Vicini FA. Breast-cancer related lymphedema: a review of procedure-specific incidence rates, clinical assessment AIDS, treatment paradigms, and risk reduction. Breast J. 2012;18:357\u201361.","journal-title":"Breast J"},{"key":"13513_CR36","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1200\/JCO.2008.17.9291","volume":"27","author":"SA Norman","year":"2009","unstructured":"Norman SA, Localio AR, Potashnik SL, Simoes Torpey HA, Kallan MJ, Weber AL, et al. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol. 2009;27:390\u20137.","journal-title":"J Clin Oncol"},{"key":"13513_CR37","first-page":"5","volume":"4","author":"K Ayre","year":"2019","unstructured":"Ayre K, Parker C. Lymphedema after treatment of breast cancer: a comprehensive review. J Unexplored Med Data. 2019;4:5.","journal-title":"J Unexplored Med Data"},{"key":"13513_CR38","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10549-016-3993-7","volume":"160","author":"EJ Yang","year":"2016","unstructured":"Yang EJ, Ahn S, Kim E-K, Kang E, Park Y, Lim J-Y, et al. Use of a prospective surveillance model to prevent breast cancer treatment-related lymphedema: a single-center experience. Breast Cancer Res Treat. 2016;160:269\u201376.","journal-title":"Breast Cancer Res Treat"},{"key":"13513_CR39","doi-asserted-by":"publisher","first-page":"337","DOI":"10.4174\/astr.2024.106.6.337","volume":"106","author":"JS Park","year":"2024","unstructured":"Park JS, Kim YS, Kim HY, Choi Y. Lymphedema after regional nodal irradiation for breast cancer: a retrospective cohort study. Ann Surg Treat Res. 2024;106:337.","journal-title":"Ann Surg Treat Res"},{"key":"13513_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10549-014-3137-x","volume":"148","author":"S-Y Jung","year":"2014","unstructured":"Jung S-Y, Shin KH, Kim M, Chung SH, Lee S, Kang H-S, et al. Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II\/III breast cancer patients. Breast Cancer Res Treat. 2014;148:91\u20138.","journal-title":"Breast Cancer Res Treat"},{"key":"13513_CR41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10549-023-07183-9","volume":"204","author":"M Jia","year":"2024","unstructured":"Jia M, Pan L, Yang H, Gao J, Guo F. Impact of neoadjuvant chemotherapy on breast cancer-related lymphedema after axillary lymph node dissection: a retrospective cohort study. Breast Cancer Res Treat. 2024;204:223\u201335.","journal-title":"Breast Cancer Res Treat"},{"key":"13513_CR42","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1089\/lrb.2014.0030","volume":"12","author":"M-J Lee","year":"2014","unstructured":"Lee M-J, Beith J, Ward L, Kilbreath S. Lymphedema following taxane-based chemotherapy in women with early breast cancer. Lymphat Res Biol. 2014;12:282\u20138.","journal-title":"Lymphat Res Biol"},{"key":"13513_CR43","first-page":"687","volume":"149","author":"B Brismar","year":"1983","unstructured":"Brismar B, Ljungdahl I. Postoperative lymphoedema after treatment of breast cancer. Acta Chir Scand. 1983;149:687\u20139.","journal-title":"Acta Chir Scand"},{"key":"13513_CR44","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1245\/s10434-017-5960-x","volume":"24","author":"TT Nguyen","year":"2017","unstructured":"Nguyen TT, Hoskin TL, Habermann EB, Cheville AL, Boughey JC. Breast cancer-related lymphedema risk is related to multidisciplinary treatment and not surgery alone: results from a large cohort study. Ann Surg Oncol. 2017;24:2972\u201380.","journal-title":"Ann Surg Oncol"},{"key":"13513_CR45","first-page":"691","volume":"24","author":"TA de la Pared","year":"2006","unstructured":"de la Pared TA. y Mama A: Anatomy of the thoracic wall, axilla and breast. Int J Morphol. 2006;24:691\u2013704.","journal-title":"Int J Morphol"},{"key":"13513_CR46","volume-title":"Pathophysiology of lymphedema. Lymphedema: Presentation, diagnosis, and treatment","author":"G Hespe","year":"2015","unstructured":"Hespe G, Matthew D, Babak J. Pathophysiology of lymphedema. Lymphedema: Presentation, diagnosis, and treatment. Switzerland: Springer; 2015."},{"key":"13513_CR47","first-page":"1587","volume":"23","author":"ML Kwan","year":"2012","unstructured":"Kwan ML, Haque R, Lee VS, Joanie Chung W, Avila CC, Clancy HA, et al. Validation of AJCC TNM staging for breast tumors diagnosed before 2004 in cancer registries. CCC. 2012;23:1587\u201391.","journal-title":"CCC"},{"key":"13513_CR48","unstructured":"Gland P. Seer program: comparative staging guide. 1993."},{"key":"13513_CR49","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.ijrobp.2007.11.036","volume":"71","author":"TA Buchholz","year":"2008","unstructured":"Buchholz TA, Woodward WA, Duan Z, Fang S, Oh JL, Tereffe W, et al. Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodes. Int J Radiat Oncol Biol Phys. 2008;71:1022\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"13513_CR50","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/jnci\/93.2.96","volume":"93","author":"VS Erickson","year":"2001","unstructured":"Erickson VS, Pearson ML, Ganz PA, Adams J, Kahn KL. Arm edema in breast cancer patients. JNCI. 2001;93:96\u2013111.","journal-title":"JNCI"},{"key":"13513_CR51","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10549-016-4089-0","volume":"162","author":"SF Shaitelman","year":"2017","unstructured":"Shaitelman SF, Chiang Y-J, Griffin KD, DeSnyder SM, Smith BD, Schaverien MV, et al. Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis. Breast Cancer Res Treat. 2017;162:201\u20135.","journal-title":"Breast Cancer Res Treat"},{"key":"13513_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-021-08024-y","volume":"21","author":"Q Yuan","year":"2021","unstructured":"Yuan Q, Hou J, He Y, Liao Y, Zheng L, Wu G. Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level. BMC Cancer. 2021;21:1\u201310.","journal-title":"BMC Cancer"},{"key":"13513_CR53","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s12282-022-01395-5","volume":"30","author":"T Konishi","year":"2023","unstructured":"Konishi T, Tanabe M, Michihata N, Matsui H, Nishioka K, Fushimi K, et al. Risk factors for arm lymphedema following breast cancer surgery: a Japanese nationwide database study of 84,022 patients. Breast Cancer. 2023;30:36\u201345.","journal-title":"Breast Cancer"},{"key":"13513_CR54","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jamcollsurg.2008.12.001","volume":"208","author":"JL Gnerlich","year":"2009","unstructured":"Gnerlich JL, Deshpande AD, Jeffe DB, Sweet A, White N, Margenthaler JA. Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. J Am Coll Surg. 2009;208:341\u20137.","journal-title":"J Am Coll Surg"},{"key":"13513_CR55","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10549-014-2856-3","volume":"144","author":"CL Miller","year":"2014","unstructured":"Miller CL, Specht MC, Skolny MN, Horick N, Jammallo LS, O\u2019Toole J, et al. Risk of lymphedema after mastectomy: potential benefit of applying ACOSOG Z0011 protocol to mastectomy patients. Breast Cancer Res Treat. 2014;144:71\u20137.","journal-title":"Breast Cancer Res Treat"},{"key":"13513_CR56","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1200\/JCO.2008.16.3766","volume":"26","author":"SA McLaughlin","year":"2008","unstructured":"McLaughlin SA, Wright MJ, Morris KT, Sampson MR, Brockway JP, Hurley KE, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors. J Clin Oncol. 2008;26:5220.","journal-title":"J Clin Oncol"},{"key":"13513_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-014-0414-x","volume":"16","author":"K Togawa","year":"2014","unstructured":"Togawa K, Ma H, Sullivan-Halley J, Neuhouser ML, Imayama I, Baumgartner KB, et al. Risk factors for self-reported arm lymphedema among female breast cancer survivors: a prospective cohort study. Breast Cancer Res. 2014;16:1\u201315.","journal-title":"Breast Cancer Res"},{"key":"13513_CR58","first-page":"3518","volume":"110","author":"HR Ahn","year":"2024","unstructured":"Ahn HR, Jeong HE, Jeong C, Kang SY, Jung SH, Youn HJ, et al. Incidence and risk factors of breast cancer-related lymphedema in Korea: a nationwide retrospective cohort study. Int J Surg. 2024;110:3518\u201326.","journal-title":"Int J Surg"},{"key":"13513_CR59","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.5535\/arm.2017.41.6.1065","volume":"41","author":"P Kim","year":"2017","unstructured":"Kim P, Lee JK, Lim OK, Park HK, Park KD. Quantitative lymphoscintigraphy to predict the possibility of lymphedema development after breast cancer surgery: retrospective clinical study. Ann Rehabil Med. 2017;41:1065\u201375.","journal-title":"Ann Rehabil Med"},{"key":"13513_CR60","unstructured":"Park E. Evaluating the consistency of health insurance claim disease code and medical record and improvement plan. Wonju, Korea: Health Insurance Review & Assessment Service; 2018. p. 1\u2013287. https:\/\/repository.hira.or.kr\/handle\/2019.oak\/730."},{"key":"13513_CR61","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1089\/lrb.2013.0004","volume":"11","author":"S Ugur","year":"2013","unstructured":"Ugur S, Ar\u0131c\u0131 C, Yaprak M, Mesc\u0131 A, Ar\u0131c\u0131 GA, Dolay K, Ozmen V. Risk factors of breast cancer-related lymphedema. Lymphat Res Biol. 2013;11:72\u20135.","journal-title":"Lymphat Res Biol"},{"key":"13513_CR62","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2147\/CLEP.S129785","volume":"9","author":"AB Pedersen","year":"2017","unstructured":"Pedersen AB, Mikkelsen EM, Cronin-Fenton D, Kristensen NR, Pham TM, Pedersen L, et al. Missing data and multiple imputation in clinical epidemiological research. Clin Epidemiol. 2017;9:157\u201366.","journal-title":"Clin Epidemiol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13513-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13513-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13513-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T07:18:57Z","timestamp":1737530337000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13513-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13513"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13513-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]},"assertion":[{"value":"8 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures contributing to this work complied with the ethical standards of the relevant national and institutional committees on human experimentation and the Helsinki Declaration of 1975, as revised in 2008. As the NHIS data did not contain any identifying information, the study was approved by the Institutional Review Board of Seoul National University Hospital (E-2206\u2013076-1332). Because we used de-identified data, the need for informed consent was waived by the Institutional Review Board of Seoul National University Hospital (E-2206\u2013076-1332).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}